Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.

Share:
More In Business
Will We See A Recession In 2025?
Managing Principal and CEO of Peachtree Group, Greg Friedman, joins Cheddar's Dave Briggs to discuss the possibility of a recession in 2025. Watch!
Load More